Cover |
Apr. 13, 2021 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K/A |
| Amendment Flag | true |
| Amendment Description | On April 13, 2021, Augmedix, Inc. (the “Company”) filed a current report on Form 8-K (the “Original Report”) furnishing on Exhibit 99.1 thereto the Company’s unaudited quarterly financial results for 2020 and 2021. This Amendment No. 1 on Form 8-K/A (the “Amended Report”) is being filed to correct an inadvertent error in Exhibit 99.1 regarding the net loss amount for the fourth quarter ended December 31, 2020. The Original Report reported a net loss of $3.971 million for the fourth quarter ended December 31, 2020, but the correct net loss amount for such quarter is $3.791 million. This Amended Report supersedes and replaces the Original Report in its entirety. |
| Document Period End Date | Apr. 13, 2021 |
| Entity File Number | 000-56036 |
| Entity Registrant Name | AUGMEDIX, INC. |
| Entity Central Index Key | 0001769804 |
| Entity Tax Identification Number | 83-3299164 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 111 Sutter Street |
| Entity Address, Address Line Two | Suite 1300 |
| Entity Address, City or Town | San Francisco |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 94104 |
| City Area Code | (888) |
| Local Phone Number | 669-4885 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
| Entity Information, Former Legal or Registered Name | N/A |